Form 4 for XYL Xylem Inc.
Accepted 2025-03-07 00:00:00 ET · period of report 2025-03-07 · accession 0001562180-25-002198 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-07 | 2025-03-07 | XYL | McShane Geri-Michelle | VP, CAO, Ctrl | M - OptEx | $80.66 | +3,119 | 8,069 | +63% | +$251.6K |
| D | 2025-03-07 | 2025-03-07 | XYL | McShane Geri-Michelle | VP, CAO, Ctrl | S - Sale+OE | $128.18 | -4,119 | 3,950 | -51% | -$528.0K |
| D | 2025-03-07 | 2025-03-07 | XYL | McShane Geri-Michelle | VP, CAO, Ctrl | M - OptEx | $0.00 | -3,119 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-07 | M | A | 3,119 | $80.66 | 8,069 | D | — | — | |
| 2 | Common | Common Stock | 2025-03-07 | S | D | 4,119 | $128.18 | 3,950 | D | — | — | (F1) This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 4,119 Shares were executed at a range of prices from $127.50 to $128.38. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
| 3 | Derivative | Non-Qualified Stock Options (Right to Buy) | 2025-03-07 | M | D | 3,119 | $0.00 | 0 | D | $80.66 · — to 2030-02-27 | 3,119 Common Stock | (F2) The February 27, 2020 option grant vested 1,030 options on February 27, 2021, 1,029 options on February 27, 2022, and 1,060 options on February 27, 2023. |